and a NASH diagnostic called NIS4. A phase 3 trial of elafibranor in PBC is due to start later this year. NASH is a fast-progressing condition characterised by liver scarring and inflammation ...
After hours: March 21 at 4:00:16 PM EDT Loading Chart for GNFT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback